This month at #ISNTweetorial, we thought it would be fun to visit ancient Greece! Well not the whole of ancient Greece. But we did visit a particular Greek goddess. Can you guess which one? 🤔
(Image: Wikipedia)
🎥The #ISNTweetorial team proudly presents - an epic story (with all the drama of ancient Greece) - ‘The pathogenesis of chronic kidney disease - mineral bone disease’
The curtain opens to phosphorus(P). In CKD, as the kidney function declines, the ability of the kidney to excrete P ⬇️
Once the eGFR falls below 60 mL/min/1.73m2, filtration of P ⬇️ and it begins to get retained (Image: flickr)
Why do we care so much about P? Well because as the levels of P ⬆️, two things happen:
1️⃣Calcium(Ca) level ⬇️
2️⃣Active vitamin D (calcitriol) synthesis and activity ⬇️
Parathyroid hormone(PTH) kicks into action to ⬇️ reabsorption of P by the proximal tubules 👍
PTH also ⬆️ bone resorption to maintain Ca level 👍
Moreover, it ⬆️ calcitriol production.
But here’s the catch ➡️
In what has been described as the ‘trade-off’ hypothesis, ⬆️ PTH does help to regulate levels of P, Ca and calcitriol. But the trade off is hyperparathyroidism 😱 cjasn.asnjournals.org/content/5/9/17…
But the main hero 🦸of our story is not PTH, but fibroblast growth factor 23 or FGF-23. Even before low P levels are noted, FGF-23 flips the ‘off’ 🚫button on Vit D
⬇️Calcitriol levels➡️⬇️ reabsorption of P by the kidneys and ⬇️absorption of P by the intestine
In fact, FGF-23 enters into the story much earlier than PTH - maybe even when the eGFR is at 90 ml/min/1.73 m2!
So the actual trade off?
You guessed it - ⬇️vitamin D, which in turn leads to ⬇️ Ca (and ultimately ⬆️ P and ⬆️ PTH)
And what about Vitamin D?
In CKD, there are multiple mechanisms by which active Vit D levels can⬇️
✅⬇️ 1 alpha hydroxylase activity
✅Hyperphosphatemia
✅⬆️ FGF23
(Source: Comprehensive Clinical Nephrology, 6th edition)
As calcitriol level ⬇️, PTH charges in ⚡️guns blazing to maintain it. And that does help initially🙂
Ultimately, however, this response becomes maladaptive 🙁 and the bones simply say ‘no go’ (skeletal resistance to PTH).
To summarize
⬇️ eGFR → ⬆️ FGF23 → ⬇️ calcitriol → ⬇️ Ca → ⬆️ PTH
⬇️ eGFR → ⬆️ P → ⬇️ Ca and ⬇️ calcitriol → ⬆️ PTH
⬇️ eGFR → ⬇️ calcitriol → ⬆️ PTH
Too much PTH → skeletal resistance to PTH → crazy high P and low Ca → CKD-MBD
Now I know what you are thinking - where’s the Greek goddess in all this?🤷♀️
⚡️Introducing Clotho, Goddess of Fate⚡️
Clotho and her sisters Atropos and Lachesis constituted the Fates or the Moirai
Clotho had the power to choose who was born and who was to die
(Image:Wikipedia)
Interesting. But what does that have to do with CKD-MBD?
Well Klotho was the name chosen for the obligate co-receptor of FGF-23. In other words, Klotho is the patron goddess of our hero, FGF-23 kidney-international.org/article/S0085-…
A ‘klotho centric’ theory argues that the klotho gene is a putative anti-ageing gene and CKD is a state of accelerated ageing
As early as CKD stage 1, the expression of klotho declines
⬇️ Klotho ➡️ ⬇️ FGF23 ➡️ ⬆️ PTH ➡️ CKD-MBD
What we are basically trying to say is that CKD-MBD might actually be a state of 'klotho deficiency'🤯
Gives you something to think about doesn't it?
(Image: istockphoto)
What do you think about the Klotho theory of CKD-MBD?
That's all for today folks!
Keep watching this space for more on CKD-MBD and its management - The amazing @gag_aggarwal will be releasing a tweetorial soon!
Think you already know all there is to know? Wait for the quiz! It’s coming soon
Lucky winners will be blessed by Clotho herself!
Ok maybe that was a joke
But you do get an e-certificate from the ISN🥇🥈🥉
1/13 Use of Direct Oral Anticoagulants (DOACs) in Kidney Disease
☑️⬇️ Better bleeding risk profile
☑️No need for monitoring!
☑️Faster action
☑️ less drug & dietary interactions
☑️?⬇️ risk of Vascular calcifications
👉@Kidney_Int kidney-international.org/article/S0085-…
🧵by @gag_aggarwal
2/ Originally referred to as new/novel/non-VKA oral anticoagulants (NOACs)
the preferred international consensus nomenclature for OACs that directly inhibit 1 molecular target is ->DOAC
Also they are not new anymore🙈been around since early 2000s ahajournals.org/doi/full/10.11…
Check out this excellent review in @KIReports of a very important topic relevant to all clinicians involved in the care of CKD pts.
▶️Pts with CKD are at ⬆️sed risk of CAD with ⬇️ing eGFR
▶️Many CKD pts have atypical presentations of CAD; presenting more often with MI directly and more NSTEMI
▶️Risk stratification calculators like the Framingham criteria are inadequate and underestimate the risk in CKD pts
▶️Addition of eGFR/albuminuria/biomarkers can improve sensitivity but remains suboptimal
▶️Dialysis is an independent risk factor; ⬆️Sudden Cardiac Death⬆️CHF
Important study published in @KIReports. The 1st report from the developing world 🇮🇳 looking at the outcome of dialysis in #COVID19 positive patients.
▶️Majority of patients were male and older and had been on dialysis for some time.
▶️And presented with symptoms necessitating a #COVID19 test.
▶️A good 30% were referred because their home unit didn't have facilities to dialyse Covid+ve patients.
▶️ The prevalence of #Covid19 was 20% higher in dialysis pts than the general population for the same time period
▶️ Close to a quarter of Covid+ve dialysis pts died
▶️ The usual suspect co-morbidities predicted worse outcomes; diabetes,HTN, Older age, longer dialysis vintage